AstrazenecaAZN
13F holders, Q4 2024 (December 31)3holders −1
0new positions
1sold out
$139.69avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Astrazeneca PLC (AZN) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Boston Common Asset Management, LLC ($28.3M), FNY Investment Advisers, LLC ($2.1M) and Raffa Wealth Management, LLC ($36K).
- Company
- Astrazeneca PLC
- CUSIP
- G0593M107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $156K |
All 13F filers, Q3 2024 → Q4 2024: 80 shares bought and 46,499 shares sold, net −46,419 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Boston Common Asset Management, LLC | 0.82% | Reduce -17.4% | 216,775 | $28.3M |
| FNY Investment Advisers, LLC | 1.10% | No change | 200 | $2.1M |
| Raffa Wealth Management, LLC | 0.01% | Add +17.2% | 544 | $36K |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC the manager owns.